Viewing StudyNCT00529568



Ignite Creation Date: 2024-05-05 @ 6:39 PM
Last Modification Date: 2024-10-26 @ 9:36 AM
Study NCT ID: NCT00529568
Status: COMPLETED
Last Update Posted: 2013-11-05
First Post: 2007-09-12

Brief Title: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Hepatitis C Chronic
Keywords:
Name View
platelets View
hepatitis C View
ribavirin View
Hepatitis C-related thrombocytopenia View
thrombopoietin View
peginterferon alfa-2b View